PREGNANCY AND LYMPHOMAS: MANAGEMENT TACTICS, PRINCIPLES IN DIAGNOSIS AND TREATMENT


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Based on foreign investigators’ data and his findings, the author has developed and summarized indications for and contraindications to pregnancy prolongation, as well as pregnancy management tactics in women with lymphomas. An analysis of children’s physical development and the rate of congenital and acquired diseases in newborn infants born to mothers who fell ill with hemoblastoses during pregnancy or sustained this disease and gave birth in complete remission showed no significant differences from those in the general population. Pregnancy and its maintenance at any stage of the disease fail to affect therapeutic efficiency and life span in patients with lymphomas.

Texto integral

Acesso é fechado

Sobre autores

R. SHMAKOV

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Email: mdshmakov@km.ru

Bibliografia

  1. Демина Е.А. Современная терапия первичных больных лимфомой Ходжкина: Автореф. дис.. д-ра мед. наук. — М., 2006.
  2. Клиническая онкогематология: Руководство для врачей / Под ред. М. А. Волковой. — М.: Медицина, 2007.
  3. Клиническая онкология / Под ред. М. И. Давыдова. — М.: РЛС, 2004. — С. 660-665.
  4. Пылова И.В. Репродуктивная функция у женщин, больных лимфомой Ходжкина. Влияние беременности и родов на течение заболевания: Автореф. дис.. канд. мед. наук. — М., 2007.
  5. Шмаков Р. Г. Репродуктивное здоровье женщин с онкогематологическими заболеваниями: Автореф. дис.. д-ра мед. наук. — М., 2008.
  6. Aviles A., Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero // Clin. Lymphoma. — 2001. — Vol. 2, № 3. — P. 173-177.
  7. Doll D.C., Ringenberg Q.S., Yarbro J.W. Antineoplastic agents and pregnancy // Semin. Oncol. - 1989. - Vol. 16, № 5. -P. 337—346.
  8. Lishner M., Koren G. Cancer chemotherapy during pregnancy. Consortium of cancer in pregnancy evidence // Can. Fam. Physician. — 2001. — Vol. 47. — P. 41-42.
  9. Pavlidis N.A. Coexistence of pregnancy and malignancy // Oncologist. — 2002. —№ 7. — P. 279-287.
  10. Silva P.T., de Almeida H.M., Principe F. et al. Non-Hodgkin lymphoma during pregnancy // Eur. J. Obstet. Gynecol. Reprod. Biol. — 1998. — Vol. 77, № 2. — P. 249-251.
  11. Zemlickis D., Lishner M., Degendorfer P. et al. Fetal outcome after in utero exposure to cancer chemotherapy. Zemlickis, // Arch. Intern. Med. - 1992. - Vol. 152, № 3. - P. 573—576.
  12. Zwitter M., Zakelj M.P., Kosmelj K. A case-control study of Hodgkin’s disease and pregnancy // Br. J. Cancer. — 1996. — Vol. 73, № 2. — P. 246-251.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Bionika Media, 2011

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies